Second-line (2L) treatment patterns and clinical outcomes among real-world (RW) patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with FOLFIRINOX (FFX) or gemcitabine + ...
Preclinical development of the lipid nanoparticle–based mRNA vaccine with multiple natural T cell epitopes for pancreatic cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results